glp 1 tirzepatide vs semaglutide Semaglutide: what's the difference? 👀 Both are game-changers in metabolic medicine — but they don't work exactly the same: ✨ → Mimics GLP-1 only → Reduces appetite → Slows tirzepatide vs semaglutide mechanism difference

This shift in fat distribution carries particular health implications, as visceral adiposity is associated with increased cardiovascular risk, type 2 diabetes, and metabolic syndrome

Ive experienced firsthand the benefits of improved glycemic control and satiety

Can GLP-1 medications cause kidney problems

The key is talking to your doctor now about where you stand and getting your care plan in place before July 1

On the basis of results of the most recent CVOTs (DAPA-HF, DAPA-CKD, EMPEROR-R), the FDA has approved dapagliflozin (2020) and empagliflozin (2021) to reduce risk for CV death and HF hospitalization in adults with HF and reduced ejection fraction regardless of whether they have diabetes [24, 25]